• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Waiving Co-pays and Deductibles Waves a Red Flag

Article

As co-pays and deductibles in Medicare and commercial health plans become more prevalent, so, too, does the temptation to waive them. But beware.

If providers routinely waive forms of cost-sharing, such as co-pays and deductibles, or advertise “no out-of-pocket costs,” or “insurance-only billing,” they not only hurt their practice’s financial health, they may be committing insurance fraud and abuse.

Patients are responsible for copayments and deductibles. When providers routinely waive co-insurance requirements, it is unlawful because it results in: 1) false claims, 2) violations of the federal Anti-Kickback Statute, and 3) excessive use of items and services paid for by Medicare.

The only legitimate reason to waive co-pays and deductibles is the patient’s genuine financial hardship. Documentation in patients’ own handwriting must include income; assets; expenses, including the local cost of living; family size; and the extent of their medical bills.

Some providers naively waive co-pays and deductibles to be “good guys” and help patients or to save the expense and hassle of chasing the funds after service. However, when providers do this, they misrepresent true charges, inflate health plan costs, and increase taxpayer burdens.

For example, if a provider, practitioner, or supplier claims that a service charge is $100, but routinely waives the co-pay, the actual charge is $80. Medicare should pay 80% of $80 ($64), not 80% of $100 ($80). As the sign said in my father’s hardware store, “There is no free lunch.” Someone has to cover the $16 payment discrepancy and usually it is all of us as health consumers and taxpayers.

Practitioners who knowingly commit healthcare claims fraud by waiving copays and deductibles, face dire consequences. By showing ”reckless disregard of the law,” they face, in addition to staggering legal fees and criminal and administrative fines, exclusion from participating in federal healthcare programs, not to mention loss of their credibility, reputation, practice, livelihood, and freedom if they land in prison.

Consider the case of Asad Qamar, MD, the nation’s top Medicare billing cardiologist ($18 million) in 2012. The Sarasota, Florida, physician is facing multiple lawsuits claiming he performed possibly thousands of unnecessary medical procedures, and paid patients kickbacks by waiving their Medicare copayments to encourage them to approve more medical procedures. Dr Qamar and the Institute of Cardiovascular Excellence allegedly billed for expensive and risky interventional procedures when, in fact, less costly procedures were performed, defrauding the federal and state government of tens of millions of dollars.

“Physicians should make medical decisions on the basis of their patients’ needs,” said A. Lee Bentley, US attorney for the Middle District of Florida. “Performing medically unnecessary procedures solely to line a physician’s pockets strains our healthcare system, and can also jeopardize the health and safety of patients.”

To avoid any impropriety and keep their practice—not to mention patients—healthy, providers should implement and enforce sound policies and procedures that address the issue of co-pays and deductibles. Recognizing that the chances of collecting from a patient drop 16% as soon as the patient leaves and chasing copays loses revenue, front office staff should collect co-insurance assiduously at the time of service.

For more information from the Office of Inspector General on the Anti-Kickback Statute and other fraud and abuse authorities, visit https://oig.hhs.gov.

Related Videos
Screenshot of an interview with James Chambers, PhD
dr ian neeland
dr manisha jhamb
dr john m. o'brien
Ali Khawar
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Carrie Kozlowski
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.